GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO BTA) » Definitions » 3-1 Month Momentum %

Vicore Pharma Holding AB (OSTO:VICO BTA) 3-1 Month Momentum % : N/A% (As of Jul. 14, 2025)


View and export this data going back to . Start your Free Trial

What is Vicore Pharma Holding AB 3-1 Month Momentum %?

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2025-07-14), Vicore Pharma Holding AB's 3-1 Month Momentum % is N/A%.

The industry rank for Vicore Pharma Holding AB's 3-1 Month Momentum % or its related term are showing as below:

OSTO:VICO BTA's 3-1 Month Momentum % is not ranked *
in the Biotechnology industry.
Industry Median: 11.885
* Ranked among companies with meaningful 3-1 Month Momentum % only.

Competitive Comparison of Vicore Pharma Holding AB's 3-1 Month Momentum %

For the Biotechnology subindustry, Vicore Pharma Holding AB's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicore Pharma Holding AB's 3-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicore Pharma Holding AB's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Vicore Pharma Holding AB's 3-1 Month Momentum % falls into.


;
;

Vicore Pharma Holding AB  (OSTO:VICO BTA) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicore Pharma Holding AB  (OSTO:VICO BTA) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Vicore Pharma Holding AB 3-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's 3-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicore Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2b development for IPF. The company also has an investigational medical device in clinical development, namely, Almee, which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines